JACOB KELTON: Open Payments
NPI 1730583840 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,112 in 53 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,193 · 2025 $1,112
Food & beverage: $1,111Education: $0
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 9 | $225 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $173 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $162 |
| AstraZeneca Pharmaceuticals LP | 7 | $115 |
| Ardelyx, Inc. | 4 | $115 |
| Fresenius USA Marketing, Inc. | 4 | $99 |
| Novartis Pharmaceuticals Corporation | 2 | $77 |
| Travere Therapeutics, Inc. | 3 | $58 |
| Novo Nordisk Inc | 3 | $51 |
| Amgen Inc. | 1 | $19 |
Products named: TARPEYO, Kerendia, JARDIANCE, FARXIGA, IBSRELA, VELPHORO, Fabhalta, Rybelsus.
Industry payments across TX — which companies pay providers there.
